MiMedx Group, Inc (MDXG): Guidance Up News

MDXG – Sees prelim Q3 revs $84.6 mln vs $79.30 mln.


Key Facts Surrounding This News Item


  • MDXG had a POWR Rating of D (Sell) coming into today.
  • MDXG was -3.45% below its 10-Day Moving Average coming into today.
  • MDXG was -7.18% below its 20-Day Moving Average coming into today.
  • MDXG was -19.12% below its 50-Day Moving Average coming into today.
  • MDXG was -19.77% below its 100-Day Moving Average coming into today.
  • MDXG was -3.34% below its 200-Day Moving Average coming into today.
  • MDXG had returned +32.28% year-to-date leading up to today’s news, versus a +15.23% return from the benchmark S&P 500 during the same period.

More Info About MiMedx Group, Inc (MDXG)


MiMedx Group developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. The company was founded in 2008 and is based in Marietta, Georgia. View our full MDXG ticker page with ratings, news, and more.

MDXG at a Glance

MDXG Current POWR Rating™
Overall POWR Rating™
MDXG Current Price $12.25 5.15%
More MDXG Ratings, Data, and News

MDXG Price Reaction

The day of this event (Oct. 10, 2017)
MDXG Closing Price$12.35 5.38%
MDXG Volume5,001,500
271.08% from avg
Leading up to this event
MDXG 1-mo returnN/A%
After this event
MDXG 1-day return5.33%
MDXG 3-day return11.21%
MDXG 5-day return15.20%

MDXG Price Chart



More MiMedx Group, Inc (MDXG) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All MDXG News
Page generated in 0.7287 seconds.